Lonza Group (FRA:LO3) Beginning Cash Position: €783 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LO3 Lonza Group Ltd FRA:LO3
82 GF Score
Price €582.40
GF Value €624.99
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lonza Group Beginning Cash Position?

Lonza Group FRA:LO3 -5.05% 82 Beginning Cash Position is €783 Mil as of Jun. 2026. GuruFocus rates FRA:LO3 with a GF Score™ of 82/100 and a GF Value™ of €624.99 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Lonza Group's Beginning Cash Position for the quarter that ended in Jun. 2026 was €783 Mil.

Lonza Group's quarterly Beginning Cash Position declined from Jun. 2025 (€1,185 Mil) to Dec. 2025 (€901 Mil) and declined from Dec. 2025 (€901 Mil) to Jun. 2026 (€783 Mil).

Lonza Group's annual Beginning Cash Position increased from Dec. 2023 (€1,420 Mil) to Dec. 2024 (€1,572 Mil) but then declined from Dec. 2024 (€1,572 Mil) to Dec. 2025 (€1,120 Mil).

Lonza Group Beginning Cash Position Related Terms

Lonza Group Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Lonza Group's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lonza Group Beginning Cash Position Chart

Lonza Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 594.81 1,603.06 1,419.82 1,572.39 1,119.88

Lonza Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,525.81 1,496.34 1,184.50 901.26 782.97
FRA:LO3
82GF Score
Lonza Group Ltd FRA:LO3
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lonza Group Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €783 Mil mean?
Lonza Group (FRA:LO3) has a Beginning Cash Position of €783 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lonza Group and its competitors.
Is Lonza Group's Beginning Cash Position too high?
Lonza Group's current Beginning Cash Position is €783 Mil. Overall, Lonza Group has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lonza Group's Beginning Cash Position compare to TMO and DHR?
Lonza Group's Beginning Cash Position of €783 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lonza Group and its competitors. Lonza Group's current Beginning Cash Position is €783 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lonza Group stock overvalued right now?
Based on GuruFocus' analysis, Lonza Group (FRA:LO3) is currently considered Modestly Undervalued. The stock's GF Value™ is €624.99, compared to a current price of €582.40 — trading 6.8% below its estimated fair value. The current Beginning Cash Position is €783 Mil. Lonza Group's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Lonza Group (FRA:LO3), the current Beginning Cash Position is €783 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lonza Group (FRA:LO3) Overvalued in 2026?

Based on GuruFocus' analysis, Lonza Group stock appears to be undervalued. The current stock price of €582.40 is trading 6.8% below its estimated GF Value™ of €624.99. GuruFocus considers Lonza Group to be Modestly Undervalued.

Key valuation signals for FRA:LO3:

  • Beginning Cash Position: €783 Mil
  • GF Value™: €624.99 vs. price of €582.40 (6.8% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the FRA:LO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lonza Group Business Description

Address Muenchensteinerstrasse 38, Basel, CHE, 4002
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
82GF Score

Get the complete analysis for FRA:LO3

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€582.40
Price
€624.99
GF Value